Bertek And Amide Sue FDA To Remove Unapproved Digoxins
Executive Summary
Jerome Stevens/Duramed's digoxin tablets should be removed from the market, Bertek and Amide maintain in an Oct. 4 complaint against FDA for declaratory and injunctive relief in Washington, D.C. district court.
You may also be interested in...
King Tigan Suppository sNDA Pushed To 2004 Under Revised FDA Agreement
King has an additional two years to submit an sNDA for Tigan suppositories under an amended agreement with FDA requiring submission by December 2004
King Tigan Suppository sNDA Pushed To 2004 Under Revised FDA Agreement
King has an additional two years to submit an sNDA for Tigan suppositories under an amended agreement with FDA requiring submission by December 2004
Digoxin Timelines: Unapproved Tablets Can Remain 30 Days, Elixirs Two Years
Roxane Laboratories plans to submit an NDA for its digoxin elixir product in November, the company says